Latest Commentary
Medicine

New Zealand Case and New York Times Magazine Article Draw Attention to Physician Aid in Dying

Josephine Johnston, 05/26/2015
Are we reaching a tipping point in the debate over physician aid in dying? A case before the courts in my homeland, New Zealand, combined with a recent New Yor...
Pharmaceutics

New in Skin Care: Natural and GMO

Gregory E. Kaebnick, 05/06/2015
At the end of April, the biotech firm Amyris announced that it was launching its own line of skin emollient under the brand name Biossance. The product is base...

Sacred versus Synthetic? Nature Preservationism and Biotechnology

Gregory E. Kaebnick, 04/23/2015
One of the long-term contributions of Earth Day is that it offers a regular, semi-official reminder that a sense of the sacred is a vital part of environmental...
Recent Commentary
Bioethics and the Law

Sex, Consent, and Dementia

Bonnie Steinbock, 04/15/2015
Science and Society

A Moratorium on Gene Editing?

Gregory E. Kaebnick, 03/27/2015
Human Reproduction

DNA Phenotyping and Baby’s First Portrait

Timothy F. Murphy, 03/20/2015
Pharmaceutics

The Drug that Cried “Feminism”

Alessandra Hirsch, Rebecca Holliman, and Adriane Fugh-Berman, 03/17/2015
Connect with the Forum

Get Permissions

RSS feed

What is Bioethics Forum?
Bioethics Forum, the blog of the Hastings Center Report, publishes thoughtful commentary from a range of perspectives on timely issues in bioethics. The opinions expressed in it are those of the authors and not The Hastings Center.
On The Web

Google, Yahoo, Microsoft Barred from Advertising Sex Determination Tests by India's Supreme Court

International Business Times

"India is suffering so much because of sex ration. Still there is a state of antipathy..."

Journal editor defends retraction of GMO-rats study while authors reveal some of paper's history

Retraction Watch

"...claiming COPE guidelines somehow supports the decision [to retract] doesn't seem valid."

Big Data + Big Pharma = Big Money 

Charles Ornstein, ProPublica

"Need another reminder of how much drugmakers spend to discover what doctors are prescribing? Look no further than new documents from the leading keeper of such data."

U Faculty Calls for Review of Controversial Drug Study

Jeremy Olson, Star Tribune

 "Nearly a decade after Dan Markingson died by suicide while participating in a U of M drug trial for schizophrenics, the U’s Faculty Senate raised his death as a reason to re-examine their institution’s handling of vulnerable research subjects."  

 Make Your Wishes Known 

Ashwaq Masoodi, The Atlantic
"
The story of a 36-year-old man on life support whose family pulled the plug, and what happened next."

Transforming Diagnosis
Thomas Insel, National Institute of Mental Health
"While DSM has been described as a “Bible” for the field, it is, at best, a dictionary, creating a set of labels and defining each."